Arbutus Biopharma Corp: Form 8-K, filed May 25, 2018
Filed with the SEC on May 25, 2018 and accepted by EDGAR at May 25, 2018, 15:03 ET.
Items reported
- Item 5.07 Shareholder vote results
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001104659-18-035974. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.